IBTR Risk Estimation
Estimating IBTR and Tx Benefit
$2.99 · Designed for iPad. Not verified for macOS.
This application is a tool to estimate the risk of ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery.
It provides 10-year IBTR risk estimates and treatment effects, based on clinicopathological factors (age, pathological T stage, grade, margin status, lymphovascular invasion, hormone receptor status, HER2 status) and treatment options (radiation therapy, chemotherapy, endocrine therapy, anti-HER2 therapy). The application is available for both iPhone and iPad.
The tool was developed using a Cox proportional hazards model from a multicenter cohort of 8,938 patients and calibrated with treatment effects from the EBCTCG meta-analysis. It is designed for use in shared decision-making between patients and clinicians, as well as for educational purposes. The development methodology was presented at the 2025 ASCO Annual Meeting (Abstract No. 575) and published in JCO Clinical Cancer Informatics (Sagara et al., 2025). For further details, please refer to the publication.
Disclaimer
This application is intended for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with the treating physician. The developers assume no legal responsibility for any outcomes resulting from the use of this application.
Ratings & Reviews
- This app hasn’t received enough ratings or reviews to display an overview.
Updated the Age Rating settings.
The developer, Yasuaki Sagara, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .
Data Not Collected
The developer does not collect any data from this app.
Accessibility
The developer has not yet indicated which accessibility features this app supports. Learn More
Information
- Seller
- Yasuaki Sagara
- Size
- 8.6 MB
- Category
- Medical
- Compatibility
Requires iOS 16.6 or later.
- iPhone
Requires iOS 16.6 or later. - iPad
Requires iPadOS 16.6 or later. - Mac
Requires macOS 13.5 or later and a Mac with Apple M1 chip or later. - Apple Vision
Requires visionOS 1.0 or later.
- iPhone
- Languages
- English
- Age Rating
16+
- 16+
- Frequent
Medical Treatment information
- Copyright
- © 2025 Yasuaki Sagara

